AI revolution in lung disease care: Brainomix and Boehringer Ingelheim forge game-changing partnership
Brainomix, a leader in artificial intelligence (AI) imaging solutions, has announced a partnership with the German pharmaceutical giant Boehringer Ingelheim. This collaboration aims to enhance the care of patients suffering from fibrosing lung disease in the United States through the innovative application of AI imaging analysis. The partnership will focus on utilizing Brainomix’s FDA-cleared e-Lung […]